-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Galmed Pharmaceuticals Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
- Galmed Pharmaceuticals Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 6.29M shares, a 275% increase year-over-year.
- Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.77M shares, a 65.2% increase from 2022.
- Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.68M shares, a 2.22% increase from 2021.
- Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.64M shares, a 92.3% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)